TÜBINGEN, Germany – September 3, 2015

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced that it will present at BioCentury’s 22nd Annual NewsMakers in the Biotech Industry Conference to be held September 10, 2015 at the Millennium Broadway Hotel & Conference Center in New York City.

Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, will provide an overview of the company’s business, industry-leading mRNA technology platform, and clinical-stage development pipeline during his presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

Event: BioCentury’s 22nd Annual NewsMakers in the Biotech Industry Conference
Date:  Thursday, September 10, 2015
Time:  9:30-10:00 am (Eastern Time)
Location: Millennium Broadway Hotel & Conference Center – Breakout Room 401
Address: 145 W 44th St, New York, NY 10036
Website: www.biocentury.com/conferences/newsmakers/dates
Media Contacts

Andrew Mielach
Tiberend Strategic Advisors, New York
T +1 (212) 375-2694
E-Mail